Cases & Deals

  • Home
  • Practices
  • Omnes Capital, Merieux Equity Partners, and Elaia Partners participate in €20 million financing round of SeqOne Genomics

Share

Omnes Capital, Merieux Equity Partners, and Elaia Partners participate in €20 million financing round of SeqOne Genomics

January 2022

Client(s) Omnes Capital, Merieux Equity Partners, and Elaia Partners

Jones Day advised Omnes Capital, Merieux Equity Partners, and Elaia Partners in the €20 million financing round of SeqOne Genomics, a French-based provider of next genomic analysis solutions for personalized medicine.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.